Health + Wellness

JUST IN: EU Medicines Agency Starts Review Of Merck Oral COVID-19 Drug

A file photo of a healthcare worker holding a COVID-19 test kit. TARSO SARRAF / AFP

The European Union’s medicines watchdog said on Monday it had started a review of an oral COVID-19 medication from the United States pharmaceutical firm Merck, raising hopes for an easy-to-administer treatment for the deadly disease.

“EMA’s human medicines committee (CHMP) has started a rolling review of the oral antiviral medicine molnupiravir… developed by Merck Sharp & Dohme in collaboration with Ridgeback Biotherapeutics for the treatment of Covid-19 in adults,” the European Medicines Agency said in a statement.

More to follow…

Related posts

COVID-19 Vaccination: Nasarawa, Jigawa, Ogun Top NPHCDA Performance Ranking


South African Firm Makes Africa’s First mRNA COVID-19 Vaccine


US Donates 3.5 Million Pfizer COVID-19 Vaccines To Nigeria


Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More